These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 9856996)

  • 81. Strategies for inhibiting the effects of thrombin.
    Harker LA
    Blood Coagul Fibrinolysis; 1994 Jan; 5 Suppl 1():S47-58; discussion S59-64. PubMed ID: 8186356
    [TBL] [Abstract][Full Text] [Related]  

  • 82. The inhibition of the anticoagulant activity of heparin by platelets, brain phospholipids, and tissue factor.
    Ofosu FA; Cerskus AL; Hirsh J; Smith LM; Modi GJ; Blajchman MA
    Br J Haematol; 1984 Jun; 57(2):229-38. PubMed ID: 6733045
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Role of heparin and heparinlike molecules in thrombosis and atherosclerosis.
    Rosenberg RD
    Fed Proc; 1985 Feb; 44(2):404-9. PubMed ID: 3155697
    [TBL] [Abstract][Full Text] [Related]  

  • 84. A differential effect of low-affinity heparin on the inhibition of thrombin and factor Xa by antithrombin.
    Nordenman B; Nordling K; Björk I
    Thromb Res; 1980 Feb 1-15; 17(3-4):595-600. PubMed ID: 7368180
    [No Abstract]   [Full Text] [Related]  

  • 85. Antithrombin-independent thrombin inhibitors, but not direct factor Xa inhibitors, enhance thrombin generation in plasma through inhibition of thrombin-thrombomodulin-protein C system.
    Furugohri T; Sugiyama N; Morishima Y; Shibano T
    Thromb Haemost; 2011 Dec; 106(6):1076-83. PubMed ID: 22012070
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Anticoagulant activity of a bacterial glycopeptide.
    Akoum A; Josefonvicz J; Sigot M
    Thromb Res; 1990 Oct; 60(1):9-18. PubMed ID: 2126150
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Conformational equilibrium of the reactive center loop of antithrombin examined by steady state and time-resolved fluorescence measurements: consequences for the mechanism of factor Xa inhibition by antithrombin-heparin complexes.
    Futamura A; Beechem JM; Gettins PG
    Biochemistry; 2001 Jun; 40(22):6680-7. PubMed ID: 11380263
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Inhibition of platelet-surface-bound proteins during coagulation under flow II: Antithrombin and heparin.
    Miyazawa K; Fogelson AL; Leiderman K
    Biophys J; 2023 Jan; 122(1):230-240. PubMed ID: 36325617
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Electrostatic interactions in the heparin-enhanced reaction between human thrombin and antithrombin.
    Petersen LC; Jørgensen M
    Biochem J; 1983 Apr; 211(1):91-7. PubMed ID: 6870832
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Effect of a heparan sulphate with high affinity for antithrombin III upon inactivation of thrombin and coagulation factor Xa.
    Scully MF; Ellis V; Shah N; Kakkar V
    Biochem J; 1989 Sep; 262(2):651-8. PubMed ID: 2529852
    [TBL] [Abstract][Full Text] [Related]  

  • 91. S protein modulates the heparin-catalyzed inhibition of thrombin by antithrombin III. Evidence for a direct interaction of S protein with heparin.
    Preissner KT; Müller-Berghaus G
    Eur J Biochem; 1986 May; 156(3):645-50. PubMed ID: 3699029
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Interaction of designed sulfated flavanoids with antithrombin: lessons on the design of organic activators.
    Gunnarsson GT; Desai UR
    J Med Chem; 2002 Sep; 45(20):4460-70. PubMed ID: 12238925
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Ratios of anti-factor Xa to antithrombin activities of heparins as determined in recalcified human plasma.
    Schoen P; Lindhout T; Hemker HC
    Br J Haematol; 1992 Jun; 81(2):255-62. PubMed ID: 1322691
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Antithrombin conformation and the catalytic role of heparin. II. Is the heparin-induced conformational change in antithrombin required for rapid inactivation of thrombin?
    Peterson CB; Blackburn MN
    J Biol Chem; 1987 Jun; 262(16):7559-66. PubMed ID: 3584127
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Accelerating ability of synthetic oligosaccharides on antithrombin inhibition of proteinases of the clotting and fibrinolytic systems. Comparison with heparin and low-molecular-weight heparin.
    Olson ST; Swanson R; Raub-Segall E; Bedsted T; Sadri M; Petitou M; Hérault JP; Herbert JM; Björk I
    Thromb Haemost; 2004 Nov; 92(5):929-39. PubMed ID: 15543318
    [TBL] [Abstract][Full Text] [Related]  

  • 96. The hyperglycemic byproduct methylglyoxal impairs anticoagulant activity through covalent adduction of antithrombin III.
    Jacobson R; Mignemi N; Rose K; O'Rear L; Sarilla S; Hamm HE; Barnett JV; Verhamme IM; Schoenecker J
    Thromb Res; 2014 Dec; 134(6):1350-7. PubMed ID: 25307422
    [TBL] [Abstract][Full Text] [Related]  

  • 97. The rate-determining step of the heparin-catalyzed antithrombin/thrombin reaction is independent of thrombin.
    Pletcher CH; Nelsestuen GL
    J Biol Chem; 1982 May; 257(10):5342-5. PubMed ID: 7068594
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Antiangiogenic forms of antithrombin specifically bind to the anticoagulant heparin sequence.
    Schedin-Weiss S; Richard B; Hjelm R; Olson ST
    Biochemistry; 2008 Dec; 47(51):13610-9. PubMed ID: 19035835
    [TBL] [Abstract][Full Text] [Related]  

  • 99. The Research Progress of Direct Thrombin Inhibitors.
    Sun ZG; Yang-Liu ; Zhang JM; Cui SC; Zhang ZG; Zhu HL
    Mini Rev Med Chem; 2020; 20(16):1574-1585. PubMed ID: 31644402
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Neutralization of heparin activity by neutrophil lactoferrin.
    Wu HF; Lundblad RL; Church FC
    Blood; 1995 Jan; 85(2):421-8. PubMed ID: 7811995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.